Drawing for SYNERGENES

USPTO serial 76259610

SYNERGENES

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DEFORD, JEFFREY S
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SYNERGENES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Viviana Amzel

VIVIANA AMZEL EPIGENESIS PHARMACEUTICALS INCGENERAL COUNSEL 7 CLARK DRCRANBURY, NJ 08512UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergies and inflammation, respiratory, airway and pulmonary vasoconstriction, impeded respiration, acute respiratory distress syndrome, renal damage and failure, ischemia, supra ventricular tachycardia, adenosine stress tests, infantile respiratory distress syndrome, pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease, leukemias, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, metastatic cancers and cancers which metastasized to the lungs, breast, liver and prostate and central nervous systemABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 7, 2004MAILPAPER RECEIVED—
Jul 18, 2003ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jul 18, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Jul 18, 2003OP.SOPPOSITION SUSTAINED NO. 999999—
Jan 22, 2003OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 24, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2002NPUBNOTICE OF PUBLICATION—
Jun 12, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 5, 2002CNEAEXAMINERS AMENDMENT MAILED—
May 21, 2002REINREINSTATED—
May 10, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 22, 2002DOCKASSIGNED TO EXAMINER—
Jun 26, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance